Skip to main content
SpringerLink
Log in

Cetuximab

Filamentary keratitis treated with recombinant epidermal growth factor, and various toxicities in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kawakami H, Sugioka K, Yonesaka K, Satoh T, Shimomura Y, Nakagawa K.Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis. Journal of Clinical Oncology 29: e678-e679, No. 23, 10 Aug 2011. Available from: URL: http://dx.doi.org/10.1200/jco.2011.35.0694 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cetuximab. React. Wkly. 1373, 10 (2011). https://doi.org/10.2165/00128415-201113730-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113730-00028

Keywords

Search

Navigation